Evidence map›Paper›PMID 42261447›Full record

ReviewDrug design, development and therapy2026

Mechanisms of Traditional Chinese Medicine-Derived Alkaloids in Colorectal Cancer Therapy: Molecular Targets, Preclinical Evidence, and Translational Prospects.

Lin Guo, Wei Zhao, Haoyang Wang, Shuxuan Qiu, Ruiying Wang, Jingya Zhang, Shuo Tian, Mingsan Miao

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lin GuoDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Wei ZhaoDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Haoyang WangDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Shuxuan QiuDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Ruiying WangDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Jingya ZhangDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Shuo TianDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
Mingsan MiaoDepartment of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alkaloids are nitrogen-containing basic compounds derived from plants, characterized by complex cyclic structures. They serve as key active components in most traditional Chinese medicines (TCM) and demonstrate significant clinical value in colorectal cancer therapy. In recent years, TCM-derived alkaloids represented by berberine, matrine, and camptothecin have attracted widespread attention due to their remarkable anti-tumor activity. Research indicates that these compounds exert synergistic effects across multiple pathways and targets by modulating key signaling pathways, including Wnt/β-catenin, PI3K/Akt, etc. They play important roles in regulating tumor cell proliferation, apoptosis, invasion, and reversal of drug resistance. However, despite the significant multi-pathway and multi-target effects demonstrated by alkaloid compounds, current research has yet to provide a comprehensive and systematic review of their intervention effects on colorectal cancer. To address this gap, this review systematically examines the mechanisms of action of TCM-derived alkaloids and their nano-formulations in colorectal cancer treatment. It summarizes the molecular pathway networks regulated by these representative alkaloids and discusses their potential clinical benefits and current limitations.Building on this foundation, this paper further outlines future research directions, including structure optimization based on molecular structure considerations, targeted drug design strategies, and the prospects of alkaloid nanodelivery systems in clinical translation. The aim is to establish a systematic research framework for alkaloid-based colorectal cancer therapy and provide a theoretical basis for developing novel high-efficiency, low-toxicity treatment strategies.

Indexed as

AlkaloidsAntineoplastic Agents, PhytogenicColorectal NeoplasmsDrugs, Chinese HerbalMedicine, Chinese TraditionalAnimalsCell ProliferationHumansSignal TransductionAlkaloidsAntineoplastic Agents, PhytogenicDrugs, Chinese Herbalalkaloidsapoptosisautophagycolorectal cancergut microbiotananomedicinetraditional Chinese medicine

Identifiers

PMID42261447
PMCPMC13242773

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.